Sector
PharmaceuticalsOpen
₹112.85Prev. Close
₹118.75Turnover(Lac.)
₹0.08Day's High
₹112.85Day's Low
₹112.8552 Week's High
₹052 Week's Low
₹0Book Value
₹11.26Face Value
₹10Mkt Cap (₹ Cr.)
341.48P/E
0EPS
0Divi. Yield
0No Record Found
| Y/e 31 Mar( In .Cr) | Mar-2017 | Mar-2016 | Mar-2014 | Mar-2013 |
|---|---|---|---|---|
Equity Capital | 30.27 | 30.27 | 30.27 | 23.77 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 7.7 | 7.74 | 7.84 | 0.13 |
Net Worth | 37.97 | 38.01 | 38.11 | 23.9 |
Minority Interest |
| Y/e 31 Mar( In .Cr) | Mar-2014 | Mar-2013 | Mar-2012 | Mar-2011 |
|---|---|---|---|---|
Revenue | 0 | 0 | 0 | 0 |
yoy growth (%) | 0 | 0 | 0 | |
Raw materials | 0 | 0 | 0 | 0 |
As % of sales | 0 | 0 | 0 | 0 |
Employee costs | -0.01 | -0.02 | -0.01 | 0 |
| Y/e 31 Mar( In .Cr) | Mar-2014 | Mar-2013 | Mar-2012 | Mar-2011 |
|---|---|---|---|---|
Profit before tax | -0.08 | -0.08 | -0.06 | -0.05 |
Depreciation | -0.03 | -0.03 | -0.03 | -0.03 |
Tax paid | 0 | 0 | 0 | 0 |
Working capital | 14.73 | 4.31 | 0.01 | |
Other operating items |
| Y/e 31 Mar | Mar-2014 | Mar-2013 | Mar-2012 | Mar-2011 |
|---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | 0 | 0 | 0 | |
Op profit growth | 0.47 | 80 | 48.03 | |
EBIT growth | 0.27 | 35.38 | 16.75 | |
Net profit growth | -0.08 | 35.72 | 16.84 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
|---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd SUNPHARMA | 1,667.2 | 93.4 | 4,00,017.13 | 2,000.46 | 0.96 | 7,107.14 | 101.44 |
Divis Laboratories Ltd DIVISLAB | 6,850.8 | 82.33 | 1,81,867.21 | 667 | 0.44 | 2,536 | 561.08 |
Cipla Ltd CIPLA | 1,515.95 | 25.44 | 1,22,444.47 | 1,485.4 | 1.06 | 4,254.47 | 397.41 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 3,416.2 | 60.68 | 1,15,614.54 | 474 | 0.94 | 2,385 | 224.33 |
Dr Reddys Laboratories Ltd DRREDDY | 1,276.95 | 19.92 | 1,06,571.92 | 1,200.7 | 0.63 | 5,546.3 | 345.76 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Additional Director
Rakesh Vekariya
Additional Director
Arun Vaghasiya
Additional Director
Ramjibhai Maganbhai Patel
Additional Director
Yunusbhai Satarbhai Syya
303 Mahajben Arched Masjid,
13/A Chakala Cross Lane,
Maharashtra - 400003
Tel: -
Website: -
Email: kappacpharma@yahoo.com
19/20 Jaferbhoy Ind,
1st Floor Makwana Rd, Marol Naka,
Mumbai - 400 059
Tel: 91-022-28594060
Website: www.adriotcorporate.com
Email: info@adroitcorporate.com
Summary
Kappac Pharma Limited does not have significant operations. Previously, it engaged in manufacturing pharmaceuticals products. Kappac Pharma was incorporated in the year 1981. The company is based in A...
Read More
Reports by Kappac Pharma Ltd
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.